Physician profile
Thinh Duong
NPI 1437181369
$5,065.85
in general payments reported to CMS, 2019-2025
24 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $835 · 2021: $3,074 · 2022: $150 · 2023: $365 · 2024: $161 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,793.72 | 2020-2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $154.27 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.55 | 2022-2025 | |
| Abbvie INC. | $121.87 | 2019-2025 | |
| Myovant Sciences INC. | $111.20 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $93.03 | 2023-2025 | Myfembree |
| Myriad Women'S Health, INC. | $72.79 | 2023 | Myrisk |
| Baxter Healthcare | $65.62 | 2023 | Tisseel, Tachosil |
| Pfizer INC. | $58.87 | 2019-2021 | |
| Sage Therapeutics, LLC | $48.05 | 2024-2025 | Zurzuvae |
| Boston Scientific Corporation | $43.67 | 2025 | Solyx Sis System |
| Coloplast Corp | $40.11 | 2019 | |
| Hologic Sales and Service, LLC | $37.38 | 2023 | Fluent Fluid Management System, Omni Hysteroscope, Myosure Tissue Removal Device |
| Coopersurgical, INC. | $37.35 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $28.67 | 2024 | Slynd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $27.92 | 2023 | Bulkamid, Axonics |
| Therapeuticsmd, INC. | $27.47 | 2019-2022 | |
| Biom'Up France Sas | $25.98 | 2020 | |
| Dexcom, INC. | $24.92 | 2024 | Dexcom G6 Transmitter |
| Ferring Pharmaceuticals INC. | $22.97 | 2019 | |
| Alydia Health | $21.24 | 2021 | |
| Daiichi Sankyo INC. | $21.19 | 2019 | |
| Davol INC. | $19.21 | 2023 | Phasix Mesh |
| Becton, Dickinson and Company | $15.80 | 2023 | Bd Onclarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thinh Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.